| Budget Amount *help |
¥4,550,000 (Direct Cost: ¥3,500,000、Indirect Cost: ¥1,050,000)
Fiscal Year 2011: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2010: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2009: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
|
|---|
| Research Abstract |
Evaluation of the relationship between pharmacological effect and blood concentration of the drug and investigation of the mechanisms for interindividual variability of the pharmacokinetics of the drug are needed to optimize the drug therapy for patients. Recently, we have clarified that the 3 step analysis is useful method to analyze the limited number of patients and/or data in the exploratory clinical trials. In the present study, we verified whether 3 step data analysis is useful to evaluate the pharmacokinetics of the drug in small or medium scale clinical trials
|
